ID24700A - Partikel hidroksiapatit berpori sebagai pembawa bahan obat - Google Patents

Partikel hidroksiapatit berpori sebagai pembawa bahan obat

Info

Publication number
ID24700A
ID24700A IDW20000937A ID20000937A ID24700A ID 24700 A ID24700 A ID 24700A ID W20000937 A IDW20000937 A ID W20000937A ID 20000937 A ID20000937 A ID 20000937A ID 24700 A ID24700 A ID 24700A
Authority
ID
Indonesia
Prior art keywords
drugs
carriers
portable
hydroxyapatite particles
hydroxyapatite
Prior art date
Application number
IDW20000937A
Other languages
English (en)
Indonesian (id)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soderbom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID24700A publication Critical patent/ID24700A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000937A 1997-11-28 1998-11-19 Partikel hidroksiapatit berpori sebagai pembawa bahan obat ID24700A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704400A SE9704400D0 (sv) 1997-11-28 1997-11-28 Porous inorganic particles as carriers for drug substances

Publications (1)

Publication Number Publication Date
ID24700A true ID24700A (id) 2000-08-03

Family

ID=20409177

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000937A ID24700A (id) 1997-11-28 1998-11-19 Partikel hidroksiapatit berpori sebagai pembawa bahan obat

Country Status (26)

Country Link
US (1) US6558703B1 (ru)
EP (1) EP1032370B1 (ru)
JP (1) JP2001524513A (ru)
KR (1) KR20010032557A (ru)
CN (1) CN1280492A (ru)
AR (1) AR016683A1 (ru)
AT (1) ATE256453T1 (ru)
AU (1) AU752044B2 (ru)
BR (1) BR9814751A (ru)
CA (1) CA2311780A1 (ru)
DE (1) DE69820674T2 (ru)
DK (1) DK1032370T3 (ru)
ES (1) ES2210840T3 (ru)
HU (1) HUP0100303A3 (ru)
ID (1) ID24700A (ru)
IL (1) IL136146A0 (ru)
NO (1) NO20002719L (ru)
NZ (1) NZ504353A (ru)
PL (1) PL340927A1 (ru)
PT (1) PT1032370E (ru)
RU (1) RU2219907C2 (ru)
SE (1) SE9704400D0 (ru)
SK (1) SK6602000A3 (ru)
TW (1) TW524694B (ru)
WO (1) WO1999027912A1 (ru)
ZA (1) ZA9810463B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924334D0 (en) * 1999-10-15 1999-12-15 Secr Defence Pharmaceutical products and methods of fabrication therefor
AU4688301A (en) * 2000-04-11 2001-10-23 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
EP2982668A3 (en) 2002-12-03 2016-04-13 Pharmacyclics LLC 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders
KR101207553B1 (ko) 2005-06-02 2012-12-03 (주)씨앤팜 금속 이중층 수산화물을 포함하는 생체 주사제용 약물 담체
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
JP5027410B2 (ja) * 2005-12-13 2012-09-19 株式会社サンギ ユビキノン含有組成物
US8287914B2 (en) * 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
GB0909460D0 (en) 2009-06-02 2009-07-15 Intrinsiq Materials Global Ltd Mesoporus material
KR102229036B1 (ko) 2013-02-01 2021-03-17 더블유.알. 그레이스 앤드 캄파니-콘. 액체 기술을 위한 담체로서의 다공성 실리카 겔
US9895314B2 (en) 2013-09-20 2018-02-20 Tillotts Pharma Ag Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
GB8713263D0 (en) 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
EP0376331A3 (en) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
US5947893A (en) * 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein

Also Published As

Publication number Publication date
JP2001524513A (ja) 2001-12-04
HUP0100303A2 (hu) 2001-08-28
IL136146A0 (en) 2001-05-20
AU752044B2 (en) 2002-09-05
NO20002719D0 (no) 2000-05-26
SK6602000A3 (en) 2001-01-18
CN1280492A (zh) 2001-01-17
EP1032370B1 (en) 2003-12-17
NO20002719L (no) 2000-07-28
BR9814751A (pt) 2000-10-03
ZA9810463B (en) 1999-05-21
SE9704400D0 (sv) 1997-11-28
ES2210840T3 (es) 2004-07-01
CA2311780A1 (en) 1999-06-10
DE69820674D1 (de) 2004-01-29
PT1032370E (pt) 2004-05-31
WO1999027912A1 (en) 1999-06-10
DK1032370T3 (da) 2004-03-15
AR016683A1 (es) 2001-07-25
EP1032370A1 (en) 2000-09-06
ATE256453T1 (de) 2004-01-15
RU2219907C2 (ru) 2003-12-27
NZ504353A (en) 2001-10-26
HUP0100303A3 (en) 2004-03-29
US6558703B1 (en) 2003-05-06
KR20010032557A (ko) 2001-04-25
TW524694B (en) 2003-03-21
AU1356399A (en) 1999-06-16
DE69820674T2 (de) 2004-09-30
PL340927A1 (en) 2001-03-12

Similar Documents

Publication Publication Date Title
ID30075A (id) Partikel gel superserap multikomponen
DE69823565D1 (de) Zerstäuber
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
NO20001776D0 (no) Medikamenter
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
EE200400122A (et) Pulberinhalaator
ATE200027T1 (de) Tetrahydrolipstatin enthaltende präparate
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
FI954098A (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
ID19841A (id) Partikel-partikel kering bebas-alir
ID25722A (id) Penganalisa partikel-partikel padat terlarut
DE69811916D1 (de) Formstabiler absorbierender artikel
ID24700A (id) Partikel hidroksiapatit berpori sebagai pembawa bahan obat
DE69836329D1 (de) Schneller und hochverstärkender operationsverstärker
DE69600800D1 (de) Träger und Packung
ID26820A (id) Aglomerat partikel
DE59813144D1 (de) Teilchenmanipulierung
ID24270A (id) Penghilang sumbatan keratotik
DE69817679D1 (de) Teilchenfilter
DE69830939D1 (de) Beschichtete Trägerteilchen
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
DE69809928D1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
ID23437A (id) Penghilang sumbatan keratotik
ID20658A (id) Pengendali jumlah gerakan partikel